Spotlight
About
News
CME/CE
Subscribe
Partnerships
Prenatal peptides promising in Down syndrome model
A mouse model suggests that prenatal treatment with neuroprotective peptides may have potential in improving learning performance in Down syndrome, according to researchers from the National Institute of Child Health and Human Development (NICHD).
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Recent Videos
Related Content
